Scenario 1 is more likely than Scenario 2
Cancer killed my mother. Now its time to help $TPST kill cancer.
DISCLAIMER I am financially invested in this stock, I have 4200 shares, and a considerable amount of calls for an unspecified date and amount. So yes, I, in a very big way, am selling you. I financially benefit if you, the investigative reader, buy CVM shares or, very possibly, calls. That means that this is not financial advice, this is a sales pitch, so if you...
The thing about SENS is that it's been a company crushing it in 2021. When it was first discussed this year it was still trading below $1. Despite recent volatility, it's up significantly year-to-date. I think volume remains steady but definitely on the lower end of the range. But good data from the last presentation on its PROMISE study seems to have sparked...
As we approach the time-based fib levels, we can see that the stock is still honoring key support levels. Ideally, when we reach the July period, we'll see some volatile price movements. Good luck traders!
The Marketmiracle advisor reported last night a major entry on the stock $MBRX with a potential profit of 300% approximately The company Moleculin Biotech has several active trials all in the field of cancer research and recently also against covid, has recently presented quarterly and annual data far above the expectations of analysts. Recently a reverse split...
According to the indicator at the base of the advisor Marketmiracle the CLVS stock is accumulating capitals and is ready for an explosion. Clovis Oncology is one of the best-selling low-cost titles but produces a drug capable of improving the lives of cancer patients worldwide. Clearly the money devoted to biotech and pharmaceutical companies during the covid...
DR JI IS BACK FOR HIS REVENGE. SRNE FALLING WEDGE AND GAP FILL TO 12s can be seen. Dr Ji will always burn the shorts. Shorts, get ready to cover yourself.
This company is going to be huge. Fundamentally : It's already passing the Phase 3 ARIEL4 study. Revenue has been beaten in last quarter report. (although there was a small overestimate for the profit(loss) per share) The MACD indicator is bouncing back (also the price is pushing through the Moving Averages). Price is now in the channel (2 thick red dot...
Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clinical data package for tesetaxel is unlikely to support FDA approval. Therefore, Odonate is discontinuing the development of tesetaxel and will wind down the operations of the Company. As of...
· Current Price – $0.0419 · Best Case Scenario PT over 1$ · Market Cap – $11 million · Debt – 0 Halbert Corporation Are a biomedical company with a clear aim to revolutionize the world of medicine. They are working towards a creation of variety of antibodies and treatments using extracorporeal techniques (outside of body). They believe they have the...
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. After an insider at Mersana Therapeutics bought shares following a May 2020 selloff triggered by an interim data release, the stock rallied over 400% during the next eight months. Another...
+ back-tested the previous AH. looking to re-test current AH and climb to a new AH. + The more Saphyrs deployed = More Rev./Earnings = Higher Share Price. + 10,000 Deployed Saphyrs GOAL 2021 according to CEO Eric. $14 PT was given based on only 600 Deployed Saphyrs. $14 x 16.666 = $233.33 PT . + Cheers to a fun week ahead. It's been a long time coming.
Major coin was dropped on options expiring this Friday....Almost like the Super Bowl! Exciting!
Shorts are doing the loyal investors a favor, they are man-making a solid resistance level to spring board from. When this hits $20, it will happen fast more than likely within hours... Just get in and sun block up... this is a long term play, not a spac, a P&D, or a penny stock... what you are witnessing is magic and it only happens once every decade or so... cheers.
Why SELLAS Life Sciences Is Surging Premarket? SELLAS Life Sciences is captivating investors thanks to its late-stage cancer vaccine Thanks to some news in December in the biopharma space, SLS stock is racing higher. So what was that news? And what else do you need to know? its leading candidate Galinpepimut-S is making its way through Phase 3. This...
$EXAS is looking strong with a potentially good entrance for a gap up. BUY signal with 8 confirmations. Happy Trading, from CJ -- aka the greatest FURU. To find out more about The Ultimate Stock Indicator on Tradingview, please check my public profile.
Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary...